Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Reinvestment Rate
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Reinvestment Rate of 2.41x as of March 2024, reinvesting $18.23 Million (capex $7.00K plus investments $-18.22 Million) from operating cash flow of $7.57 Million. Check VNDA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vanda Pharmaceuticals Inc Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for Vanda Pharmaceuticals Inc across 8 annual periods. Explore Vanda Pharmaceuticals Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Vanda Pharmaceuticals Inc (2009–2023)
Year-by-year capital reinvestment analysis for Vanda Pharmaceuticals Inc. For live market cap and broader valuation context, see Vanda Pharmaceuticals Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 8.40x | $107.54 Million | $12.80 Million | $383.00K | ▲ +423.9% |
| 2022 | 1.60x | $51.28 Million | $31.98 Million | $679.00K | ▲ +34.2% |
| 2021 | 1.19x | $76.70 Million | $64.21 Million | $552.00K | ▲ +49.0% |
| 2020 | 0.80x | $41.50 Million | $51.77 Million | $1.79 Million | ▼ -46.1% |
| 2019 | 1.49x | $68.31 Million | $45.95 Million | $1.02 Million | ▼ -59.3% |
| 2018 | 3.66x | $109.66 Million | $29.99 Million | $25.37 Million | ▲ +71.2% |
| 2015 | 2.14x | $26.60 Million | $12.45 Million | $2.53 Million | ▲ +2915.0% |
| 2009 | 0.07x | $12.00 Million | $169.34 Million | $12.00 Million | — |